Normothermic Intraperitoneal Chemotherapy (NIPEC)
Normothermic Intraperitoneal Chemotherapy (NIPEC) is an advanced approach in treating peritoneal mesothelioma. It involves applying a chemotherapeutic liquid into the abdomen at body temperature, often conducted in several stages.
A Different Approach to Mesothelioma Treatment
NIPEC is beneficial for malignant peritoneal mesothelioma and other abdominal cancers. Unlike systemic chemotherapy, which affects the entire body, NIPEC targets the abdominal area.
The Process of NIPEC Treatment
NIPEC is typically administered weeks after surgery, setting it apart from other chemotherapy washes like HIPEC and EPIC. The treatment involves multiple cycles over months and concludes with the removal of the chemotherapy port.
Advantages and Challenges of NIPEC
NIPEC offers targeted chemotherapy, which can mean fewer side effects and higher drug concentrations. However, it does require a port implantation and is not as widely available as other treatments.
NIPEC in Multimodal Treatment Plans
NIPEC often forms part of a comprehensive treatment plan, combined with other therapies. This approach has improved survival rates in peritoneal mesothelioma patients.
Side Effects
Potential side effects of NIPEC vary from bone marrow suppression to gastrointestinal issues. The severity and occurrence of these effects differ among individuals.
Availability and Accessibility
While NIPEC is a recent development in cancer treatment, its availability is still limited. Patients should consult with healthcare providers to evaluate its suitability and explore other treatment options.
NIPEC in Cancer Treatment
NIPEC represents a significant advancement in treating peritoneal mesothelioma. However, its application needs to be carefully considered by healthcare professionals for each patient.